DeepMed Research

NATIONAL INSTITUTES OF HEALTH

🇺🇸United States

Country: 🇺🇸United States

Ownership: Subsidiary, Private

Established: 1948-01-01

Employees: 1K

Market Cap: -

Website: http://www.nidcr.nih.gov

Clinical Trials

Combination Iron Chelation Therapy

Phase 1

Completed

Conditions: Iron Overload
Thalassemia

First Posted Date: 2000-03-14

Last Posted Date: 2010-01-14

Lead Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Registration Number: NCT00004982

Locations: 🇺🇸
Cornell University Medical College, New York, New York, United States

The Diabetes Prevention Trial of Type 1 Diabetes (DPT-1)

Phase 3

Completed

Conditions: Diabetes Mellitus, Type 1

Interventions: Drug: Parenteral Insulin
Other: Close Observation
Drug: Oral Insulin
Drug: Placebo

First Posted Date: 2000-03-14

Last Posted Date: 2020-04-24

Lead Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Target Recruit Count: 711

Registration Number: NCT00004984

Locations: 🇺🇸
University of Miami School of Medicine, Jackson Medical Tower, Miami, Florida, United States
🇺🇸
Children's Hospital of Pittsburgh, Dept/Pediatric Endocrinology, 3705 5th Ave, Pittsburgh, Pennsylvania, United States
🇺🇸
University of Florida Diabetes Research Center, Gainesville, Florida, United States

and more 12 locations

Education and Group Support for Diabetic Hispanics

Not Applicable

Completed

Conditions: Diabetes Mellitus, Non-Insulin-Dependent

First Posted Date: 2000-03-14

Last Posted Date: 2010-02-15

Lead Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Registration Number: NCT00004983

Locations: 🇺🇸
The University of Texas at Austin, Austin, Texas, United States

Comparison of Filgrastim and Filgrastim SD/01in Boosting White Cell Counts After Intensive Chemotherapy

Phase 1

Completed

Conditions: Synovial Sarcoma
Rhabdomyosarcoma
High-risk Sarcoma
Ewing's Sarcoma
MPNST

Interventions: Biological: Filgrastim-SD/01
Biological: Filgrastim

First Posted Date: 2000-03-06

Last Posted Date: 2019-11-12

Lead Sponsor: National Cancer Institute (NCI)

Target Recruit Count: 34

Registration Number: NCT00004853

Locations: 🇺🇸
National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States

Randomized Study of Sequential Orbital Radiotherapy for Graves' Ophthalmopathy

Not Applicable

Completed

Conditions: Graves' Disease

Interventions: Radiation: Radiotherapy
Radiation: Sham treatment

First Posted Date: 2000-02-25

Last Posted Date: 2017-05-30

Lead Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Target Recruit Count: 42

Registration Number: NCT00004660

Locations: 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States

Pilot Study of Budesonide for Patients With Primary Sclerosing Cholangitis

Phase 1

Completed

Conditions: Cholangitis, Sclerosing
Liver Cirrhosis, Biliary

Interventions: Drug: budesonide

First Posted Date: 2000-02-25

Last Posted Date: 2017-05-31

Lead Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Target Recruit Count: 22

Registration Number: NCT00004842

Locations: 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States

A Randomized Study of Surgery vs No Surgery in Patients With Mild Asymptomatic Primary Hyperparathyroidism

Not Applicable

Completed

Conditions: Hyperparathyroidism

Interventions: Other: Observation
Procedure: parathyroidectomy

First Posted Date: 2000-02-25

Last Posted Date: 2017-05-30

Lead Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Target Recruit Count: 53

Registration Number: NCT00004843

Thalidomide for the Treatment of Hormone-Dependent Prostate Cancer

Phase 3

Completed

Conditions: Prostate Cancer

Interventions: Drug: Thalidomide
Drug: leuprolide acetate
Other: Placebo
Drug: goserelin

First Posted Date: 2000-02-21

Last Posted Date: 2018-05-22

Lead Sponsor: National Cancer Institute (NCI)

Target Recruit Count: 159

Registration Number: NCT00004635

Locations: 🇺🇸
University of Minnesota, Minneapolis, Minnesota, United States
🇺🇸
Wayne State University Hutzel Hospital, Detroit, Michigan, United States
🇺🇸
University of Washington, Seattle, Washington, United States

and more 6 locations

Susceptibility to Breast Cancer

Completed

Conditions: Breast Cancer
Healthy

First Posted Date: 2000-02-14

Last Posted Date: 2019-12-16

Lead Sponsor: National Cancer Institute (NCI)

Target Recruit Count: 737

Registration Number: NCT00004565

Locations: 🇺🇸
National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States

Treatment of Peritoneal Cancer With Surgery, Perfused Heated Cisplatin and Chemotherapy

Phase 2

Completed

Conditions: Mesothelioma
Peritoneal Neoplasm
Abdominal Neoplasm
Colonic Neoplasm

Interventions: Procedure: Surgery
Procedure: Continuous hyperthermic peritoneal perfusion (CHPP) with Cisplatin
Drug: Postoperative dwell with paclitaxel and 5-FU

First Posted Date: 2000-02-04

Last Posted Date: 2015-11-18

Lead Sponsor: National Cancer Institute (NCI)

Target Recruit Count: 188

Registration Number: NCT00004547

Locations: 🇺🇸
National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy